Synthetic hepatitis B surface antigen peptide vaccine

Area of Science:

• Immunology
• Virology
• Biochemistry

Background:

• Hepatitis B virus (HBV) poses a significant global health challenge.
• The hepatitis B surface antigen (HBsAg) is a key target for HBV vaccines.
• Disulfide bonds are crucial for maintaining HBsAg structure and activity.

Purpose of the Study:

• To synthesize and characterize a specific HBsAg peptide (residues 122-137).
• To evaluate the immunogenicity of the synthetic peptide in mice.
• To explore methods for enhancing peptide immunogenicity and its potential in vaccine development.

Main Methods:

• Preparation of a synthetic HBsAg peptide (122-137) with an intrachain disulfide bond.
• Cyclization of the peptide to mimic native HBsAg structure.
• Immunization of mice with peptide formulations (liposomes, micelles, coupled to tetanus toxoid).
• Analysis of epitopes using monoclonal antibodies.
• Assessment of anti-HBs response and idiotype-anti-idiotype inhibition.

Main Results:

• The synthetic cyclic peptide contained both conformational (group a) and sequential (subgroup y) epitopes.
• An anti-HBs response was induced in mice using liposome-entrapped peptide.
• Immunogenicity was significantly enhanced by aggregation into micelles or coupling to tetanus toxoid.
• The cyclic peptide inhibited human anti-HBs idiotype-anti-idiotype reactions specific for group a determinants.

Conclusions:

• Synthetic peptides containing critical HBsAg epitopes can elicit an immune response.
• Strategies like micelle formation and conjugation enhance peptide immunogenicity.
• These findings support the potential of synthetic peptides for developing novel hepatitis B virus vaccines.